Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health


Personal tools

You are here: Home / Biomarkers / LGALS3BP



This biomarker is also known as:
  • basement membrane autoantigen p105,
  • Mac-2-binding protein,
  • MAC-2-BP,
  • M2BP,
  • lectin galactoside-binding soluble 3-binding protein,
  • L3 antigen,
  • Mac-2 BP,
  • tumor-associated antigen 90K,
  • 90K,
  • lectin, galactoside-binding, soluble, 3 binding protein,
  • BTBD17B,
  • mac-2 BP,
  • Q08380,
  • serum protein 90K,
  • Tumor-associated antigen 90K,
  • Basement membrane autoantigen p105,
  • MAC2BP,
  • galectin-3-binding protein,
  • Lectin galactoside-binding soluble 3-binding protein,

View in BioMuta


LGALS3BP is a secreted protein that binds to a human macrophage-associated lectin known as Mac-2 and also binds galectin 1. Elevated levels of LGALS3BP have been found in the serum of patients with cancer and in those infected by the human immunodeficiency virus (HIV).


QA State: Curated
Type: Protein
Short Name:


There are no datasets associated with this biomarker.


The following organs have data associated with this biomarker…



Phase: One
QA State: Under Review


Average expression of LGALS3BP was significantly higher in epithelial ovarian cancer tumors than any other normal tissue tested.

Performance Comment

LGALS3BP was one of 13 genes out of 50 selected for further validation in PMID:21617380.


This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at if you should have access to this biomarker.


The final report of the 2013 Cancer Biomarkers Bioinformatics Workshop is now available.

Announcement 03/06/2014

Thank you to everyone who helped make the 27th EDRN Steering Committee Meeting a success. We look forward to seeing everyone at the 9th EDRN Scientific Workshop from September 8-11, 2014 in Washington D.C.